Huntington Disease (HD) is a hereditary brain disease. Although the causative gene has been found, the exact mechanisms of the pathogenesis are still unknown. Recent investigations point to a metabolic and energetic dysfunction in HD neurons.
Introduction
Huntington Disease (HD) is an autosomal dominant neurodegenerative disorder, characterized by progressive motor, cognitive and psychiatric dysfunctions. Although the disease can occur at any age, the median age of onset is 40 years. Most patients die one to two decades after disease onset.
HD is caused by a mutation in the gene coding for the protein Huntingtin. The exact function of this protein is still unknown. Normal individuals have a CAGtrinucleotide repeat length of less than 37 [1] . People whose CAG repeat length exceeds this number will develop HD. The length of the CAG expansion is proportional to the severity of the disease and inversely proportional to the age of onset [2] . At present, the exact mechanism of the HD pathology is still unknown.
However, recent evidence points to metabolic and energetic dysfunction in HD neurons [2] [3] [4] . Better knowledge about this mechanism is expected to lead to more appropriate analyses, which in turn should result in a better understanding of the disease. Moreover, this will help to direct the quest for improved treatments in the proper direction.
According to Nicholson et al [5] , metabolomics is defined as 'the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modifications'. Since 1999, applications of this technique have emerged in other fields (e.g. environmental sciences) [6] . Metabolites in biofluids are in dynamic equilibrium with those in cells and tissues. A healthy individual attempts to retain the concentration of metabolites in cells and tissues constant by homeostasis. Abnormal cellular processes due to sickness, toxins, etc. result in altered biofluid compositions. Various analytical techniques are available to detect low molecular weight metabolites. The ones most commonly applied in metabolomic studies are nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS). The latter is frequently used in combination with a chromatographic separation technique (liquid chromatography, gas chromatography, etc.) [7] . Although NMR is less sensitive than MS, this technique offers some important advantages. It is a high-throughput analysis that does not require any preceding chromatographic separation or purification procedure. Additionally, sample preparation is very straightforward. Furthermore, it is a non-destructive method capable of detecting all non-exchangeable protons, provided they are present above a certain threshold concentration (µM concentrations). Moreover, the measurements are very reproducible and inexpensive on a per sample basis [8] [9] [10] . All these advantages have contributed to the application of NMR spectroscopy in clinical diagnoses of diseases and in the follow-up of subjects participating in medical treatment studies [11] .
The NMR spectrum of a biofluid is generally extremely complex in nature, since each molecule present in the biofluid gives rise to one or several peaks in most cases.
Moreover, many peaks show some fine structure and splittings which causes a prominent overlap of signals originating from different molecules [12] . Visual inspection of the spectra will therefore only reveal a small percentage of the available information [13] .
Spectral interpretation can be simplified by applying automatic data reduction methods. Subsequently, these reduced datasets can be analyzed with univariate [2, [14] [15] [16] [17] [18] [19] [20] [21] [22] or multivariate [13,23-27] statistical methods.
In this study we applied 1 H NMR spectroscopy in order to disentangle the metabolic profile of serum and cerebrospinal fluid (CSF) from a rat model for HD. Both univariate and multivariate statistical analyses were applied in a search for pathology specific differences. It is anticipated that these investigations lead to a gain in knowledge about the pathogenesis of HD and make it possible to identify some potential biomarkers.
Materials and methods

Animals
Transgenic HD rats carrying a truncated huntingtin cDNA fragment with 51 CAG repeats under the control of the native rat huntingtin promoter, and their wild-type littermates were used [28] . The expressed gene product was 75 kDa, corresponding to 22% of the full-length huntingtin (cDNA position 324-2321, amino acid position 1-709/825, corresponding to exon 1-16), which are under the control of 886 bp of the rat huntingtin promoter (position 900 to 15). Genotyping was carried out as previously described [28] . The number of CAG-repeats was analyzed in a subset of transgenic rats using these primers: cggctgaggcagcagcggctgt (forward) and ccttcgagtccctcaagtccttc (reverse). The reverse primer is labelled at the 5'end with the fluorescent dye Cy5. The PCR amplicon length was then analyzed on the Beckman coulter sequencer (CEQ 8000 Cycle Sequencer, Krefeld, Germany). In more than 15 generations only a small variation of ±1-2 CAGs were observed in transgenic rats of HD. Also for this study, in a subset of animals, the CAG-length was checked and it was found to be 51±2 CAGs. After genotyping, rats were housed in gender-and genotyped matched groups of two, according to FELASA recommendations. All rats were kept under a 12:12 hours light-dark cycle with lights on at 06.00 a.m. and food (Altromin lab chow pallets, Altromin standard diet: 1320; Lage, Germany) and tap water available ad libitum. All research and animal care procedures had been approved by the district government of Tuebingen, Germany, and followed principles described in the European Community's Council Directive of 24 th November, 1986 (86/609/EEC).
For this study, we used serum and CSF from female, transgenic HD rats (n = 10 for serum and n = 8 for CSF) at an age of two months and compared these with agematched wild-type (WT) littermates (n = 12 for serum and respectively 9 for CSF).
We are aware of the fact that the number of samples used in this study is rather small.
However, this was determined by keeping in mind the well-being of animals and in order to reduce costs. Moreover, in the literature a lot of studies where even less samples per group are investigated, can be found [15,27,29-32].
Sample collection and preparation
CSF samples
Rats were sacrificed by CO 2 inhalation and immediately exsanguinated. Subsequently, each animal was placed prone onto the stereotaxic instrument. A sagittal incision of the skin was made inferior to the occiput. The subcutaneous tissue and neck muscles through the midline were bluntly separated. Next, the rat was laid down in a way that the body made a 135° angle with the fixed head. In this angle, the dura mater of cisterna magna was exposed sufficiently. The dura was then penetrated with an insulin syringe and CSF was drawn. All samples were transferred into polypropylene tubes, 
Serum samples
Samples were taken as done previously [33] . In short: rats were sacrificed with CO 2 and blood was drawn directly from the heart. All rats were tested for diabetics immediately after sample collection. The blood was incubated for one hour at 37 °C, followed by centrifugation for 30 minutes at 3000 x g. The serum was collected and immediately stored at -80 °C until shipped for NMR analysis. Upon arrival, serum samples were immediately stored at -80 °C until measurement.
In order to keep the time spent at room temperature to a minimum, samples were randomly divided in three groups. Samples assembled in one group were prepared together. Just before their acquisition, samples were thawed to room temperature. An aliquot of serum (250 µL) from each sample was mixed with 300 µL of an aqueous saline solution. In this way, each sample contains 0.1 M NaCl and 10 % D 2 O. The addition of an internal standard like DSS is prohibited by its interaction with proteins present in the sample. Subsequently, the total volume was transferred to a 5 mm NMR tube.
1 H NMR spectroscopy
Prepared samples were analyzed on a Bruker Avance II-700 spectrometer, operating at a proton frequency of 700.13 MHz. The spectrometer is equipped with a BACS-60 automatic sample changer and a 5 mm inverse TXI-Z probe when measuring serum samples. Since the brain volume of rats is rather small, the amount of CSF that can be collected at once from one animal is too small to perform a classical NMR analysis (> 100 µL is necessary, prior to dilution to the final 550 µL measuring volume, in order to get a good S/N). Combining CSF taken from different animals within a population is not advisable, since this will remove the possibility to detect individual differences.
Recently, Bach and co-workers were zero-filled to 64 K and an exponential window function with a line broadening factor of 0.3 Hz was applied. The acquired NMR spectra were consecutively processed for phase and baseline correction. In the absence of an external reference (vide supra 2.2.2), all serum spectra were referenced to the methyl doublet of lactate at 1.33 ppm. After initial referencing of the CSF spectra using the anomeric glucose 1 H signal at 5.225 ppm, the spectra were still shifted one against the other. They were aligned using an in house developed spectral alignment algorithm (manuscript in preparation).
Data reduction of the NMR spectra
The 1 H NMR spectra were automatically reduced into consecutive integrated spectral regions (buckets) of an equal width (0.05 ppm) applying R (version 2.7.2, http://www.r-project.org). In order to eliminate spectral variations due to different quality of water suppression from one spectrum to another, the region containing the water resonance (4.5-5.0 ppm) was not included in the analysis. In order to account for differences in concentration between samples, the subdivided spectra were scaled to their total intensity.
Multivariate analysis
Prior to multivariate analysis, the data were scaled to unit variance. Besides unit variance scaling, also pareto scaling and no scaling were tested on the dataset.
However, these did not generate significant differences. Since all the variables possess an equal weight, irrespective of their absolute magnitude in the original data when unit variance scaling is applied, this method was preferred.
Principal component analysis (PCA) is used to project the data in two or three dimension in order to be able to discern outliers. This method transforms the original variables in new, uncorrelated variables or principal components (PC) in such a way that the first PC represents most of the variation present in the original dataset. Higher PC will subsequently contain less amount of the variance [5, 7, 26] . Furthermore, the number of misclassifications and the Q² value were collected. A distribution was generated for the H0 hypothesis that no difference exists between the two classes. In the permutation test, the class labels of control and disease are permutated by randomly assigning them to different individuals. With 'wrong' class labels, a classification model is again calculated. The data were permutated 1000 times. For each permutated set, the cross validation was repeated 20 times and the average parameter values were computed.
Univariate analysis
The bucket 
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PCA to detect outliers
Principal component analysis (PCA) was applied on the data in order to uncover inherent similarities and differences potentially present within the spectral profiles.
The scores plot of the first two principal components gives a representative overview of the data (figure 2).
Serum samples
The first principal component (PC1) accounts for 76.42 % of the total variation present in the dataset. The second principal component (PC2) accounts for an additional 10.02 % of the total variation. Data points lying outside the 95 % confidence ellipse (Hotelling T²) can be considered as outliers, i.e. observations that have an aberrant behaviour. As indicated in figure 2 , two data point are laying outside the Hotelling T² plot. Reconsidering these spectra reveals that the water suppression technique, which has been used while acquiring the spectra, has caused a shift of the baseline in comparison with the other spectra. This slightly different prospect is revealed by this multivariate statistical tool. However, these two spectra are not discarded for further analysis, as their differences are not from a biological nature.
CSF samples
The scores plot of the first two principal components accounts for 45.57 % of the total variation present in the CSF dataset. Possible outliers present in the dataset were uncovered by spotting the data points lying outside the 95% confidence ellipse of this scores plot. Consecutive PCA indicate three data points (one WT and two HD samples) with an aberrant behaviour (see additional file B, additional file C and additional file D). Those spectra correspond with low available volume samples (< 40 µL lyophilized). For this reason, these spectra were excluded from the dataset before further analysis.
Discrimination between normal and pathological samples using PLS-DA
A partial least squares -discriminant analysis (PLS-DA) model was developed in order to discriminate samples according to their class membership, i.e. healthy or HD.
The results of this analysis are depicted in figure 3 . The scores plot shows a reasonable separation between both sample groups. 
Serum samples
The bucket comprising both the singlet peak of the methylene groups of succinic acid and the multiplet peak of CH 2 CO of glutamine was found to be significantly different between WT and TG rats. In order to assign this statistically significant difference unambiguously to the correct metabolite, both signals were integrated referenced to the methylene singlet of creatine at 3.93 ppm. A visual representation of these results is displayed in figure 4 . These boxplots reveal that both metabolites contribute to the differentiation of the samples according to their genotype. Both glutamine (p < 0.05) and succinic acid (p < 0.005) were found to be significantly increased in HD rats compared to WT littermates. Glucose was found to be elevated in HD rats as well (p < 
CSF samples
In CSF, a student's t-test could not reveal any statistically significant metabolite concentration difference between WT and HD rats.
Discussion
In this study we have shown that rats transgenic for the HD mutation can be discriminated from healthy, wild-type littermates even prior to the onset of motor deficits [38] . A comparable study was already executed by Tsang and co-workers on a different animal model [27] . However, there are some inconsistencies between the figures and text described in their paper. The metabolites they indicated in the loadingsplot of the serum samples correspond to those mentioned for urine samples in the text and vice versa.
We used three different methods for the analysis. Visual inspection of the serum spectra already suggests that glucose as well as succinic acid levels are elevated in HD rats. These results are statistically confirmed by means of a univariate analysis.
Moreover, the Student's t-test discloses that glutamine and NAA are able to discriminate between HD and WT rats in serum samples. PLS, a supervised multivariate statistical technique, was performed in order to reveal the discriminative power of different metabolites between the studied groups. For the serum samples, the loadings which are able to separate healthy from pathological samples correspond to the metabolites glucose, glutamine, lipids, lactate, succinic acid and NAA. Regarding CSF spectra, visual inspection and univariate analysis are not able to discriminate WT from HD rats. PLS, on the other hand, distinguishes both glucose and lactate as discriminating metabolites.
As Obviously, a change in the concentration of each of these metabolites can be linked to a variety of conditions. However, the changes observed for all metabolites combined could allow for a more narrow correlation, i.e. with HD.
Conclusions
In conclusion, this study shows that metabolic alterations already emerge in the serum and CSF of these rats before overt symptoms of HD are manifested. In an early stage of the disease, metabolic alterations seem to be more pronounced in serum compared to CSF. All metabolites found being able at discriminating WT from HD rats point to a disruption of the mitochondrial respiratory chain and energy metabolism. These findings suggest that compounds which act on mitochondria might have a positive effect on HD pathology. Moreover, this study shows that 1 H NMR spectroscopy is an appropriate tool to investigate the metabolic disturbance occurring in early stages of HD. A more profound knowledge of the disease pathology can be obtained by performing a metabolomic analysis of samples originating from more mature rats.
Such an analysis could give more insight into the development of this disease, which in turn may lead to improved therapeutic interventions.
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